Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soblidotin in Advanced NSCLC
NCT00061854Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2003
- Primary completion
- May 2005
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of soblidotin in non-small cell lung cancer (NSCLC), sponsored by Daiichi Sankyo Co., Ltd.. Started Apr 2003; status: completed.
02
Drugs
soblidotin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00061854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061854.